Lv3
270 积分 2026-02-09 加入
Tirzepatide for Weight Reduction in Chinese Adults With Obesity
9天前
已完结
Tirzepatide for Obesity Treatment and Diabetes Prevention
9天前
已完结
Semaglutide once weekly as add-on to SGLT-2 inhibitor therapy in type 2 diabetes (SUSTAIN 9): a randomised, placebo-controlled trial
23天前
已完结
Tirzepatide as Compared with Semaglutide for the Treatment of Obesity
23天前
已完结
Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity
24天前
已完结
Glucagon‐like peptide‐1 receptor agonists and risk of thyroid cancer: A systematic review and meta‐analysis of randomized controlled trials
2个月前
已完结
Risk for Cancer With Glucagon-Like Peptide-1 Receptor Agonists and Dual Agonists
2个月前
已完结
Risk for Cancer With Glucagon-Like Peptide-1 Receptor Agonists and Dual Agonists
2个月前
已完结
Glucagon-like peptide-1 receptor agonists and the risk of obesity-related cancers: a systematic review and meta-analysis
2个月前
已完结
Glucagon-like peptide-1 receptor agonists and the risk of obesity-related cancers: a systematic review and meta-analysis
2个月前
已完结
皖公网安备34019202002308
